EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

The WID‐qEC test: Performance in a hospital‐based cohort and feasibility to detect endometrial and cervical cancers.

Authors

Schreiberhuber, Lena; Herzog, Chiara; Vavourakis, Charlotte D.; Redl, Elisa; Kastner, Christine; Jones, Allison; Evans, Iona; Zikan, Michal; Cibula, David; Widschwendter, Peter; Pfau, Karin; Math, Barbara; Seewald, Martin; Amory, Sylvain; Obrist, Peter; Widschwendter, Martin

Abstract

The majority of endometrial and cervical cancers present with abnormal vaginal bleeding but only a small proportion of women suffering from vaginal bleeding actually have such a cancer. A simple, operator‐independent and accurate test to correctly identify women presenting with abnormal bleeding as a consequence of endometrial or cervical cancer is urgently required. We have recently developed and validated the WID‐qEC test, which assesses DNA methylation of ZSCAN12 and GYPC via real‐time PCR, to triage women with symptoms suggestive of endometrial cancer using ThinPrep‐based liquid cytology samples. Here, we investigated whether the WID‐qEC test can additionally identify women with cervical cancer. Moreover, we evaluate the test's applicability in a SurePath‐based hospital‐cohort by comparing its ability to detect endometrial and cervical cancer to cytology. In a set of 23 cervical cancer cases and 28 matched controls the receiver operating characteristic (ROC) area under the curve (AUC) is 0.99 (95% confidence interval [CI]: 0.97‐1.00) with a sensitivity and specificity of 100% and 92.9%, respectively. Amongst the hospital‐cohort (n = 330), the ROC AUC is 0.99 (95% CI: 0.98‐1) with a sensitivity and specificity of 100% and 82.5% for the WID‐qEC test, respectively, and 33.3% and 96.9% for cytology (considering PAP IV/V as positive). Our data suggest that the WID‐qEC test detects both endometrial and cervical cancer with high accuracy.

Subjects

CERVICAL cancer; ENDOMETRIAL cancer; UTERINE hemorrhage; RECEIVER operating characteristic curves; CANCER patients; DNA methylation

Publication

International Journal of Cancer, 2023, Vol 152, Issue 6, p1269

ISSN

0020-7136

Publication type

Academic Journal

DOI

10.1002/ijc.34275

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved